ClearPoint Neuro Q3 2023 EPS $(0.20) Beats $(0.25) Estimate, Sales $5.76M Miss $6.80M Estimate
Portfolio Pulse from totan@benzinga.com
ClearPoint Neuro (NASDAQ:CLPT) reported Q3 2023 earnings per share (EPS) of $(0.20), beating the analyst consensus estimate of $(0.25) by 20%. However, the company's quarterly sales of $5.76 million missed the analyst consensus estimate of $6.80 million by 15.26%. Compared to the same period last year, the EPS decreased by 33.33% and sales increased by 11.97%.
November 09, 2023 | 9:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
ClearPoint Neuro's Q3 2023 earnings beat estimates but sales missed. The EPS decreased by 33.33% YoY, while sales increased by 11.97% YoY.
ClearPoint Neuro's mixed Q3 2023 results, with EPS beating estimates but sales missing, could lead to neutral short-term price movement. The decrease in EPS YoY might be a concern for investors, but the increase in sales YoY could be seen as a positive sign.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100